scholarly journals Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

2018 ◽  
Vol 44 (4) ◽  
pp. 438-448 ◽  
Author(s):  
Tobias Welte ◽  
R. Phillip Dellinger ◽  
Henning Ebelt ◽  
Miguel Ferrer ◽  
Steven M. Opal ◽  
...  
Keyword(s):  
Phase Ii ◽  
Polyclonal Antibody ◽  
Phase Ii Trial ◽  
Community Acquired Pneumonia ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Antibody Preparation ◽  
Multicenter Phase ◽  
Severe Community Acquired Pneumonia

scholarly journals A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low-Medium Risk

PLoS ONE ◽  
2015 ◽  
Vol 10 (2) ◽  
pp. e0117560 ◽  
Author(s):  
Ying Li ◽  
Xiao-hui Li ◽  
Zhi-jun Huang ◽  
Guo-ping Yang ◽  
Guo-gang Zhang ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Multicenter Phase ◽  
Hypertensive Population ◽  
Medium Risk

scholarly journals Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

2010 ◽  
Vol 95 (6) ◽  
pp. 2781-2789 ◽  
Author(s):  
S. Petersenn ◽  
J. Schopohl ◽  
A. Barkan ◽  
P. Mohideen ◽  
A. Colao ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Efficacy And Safety ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document